- Home
- MYO
MYO
Myomo Inc.
as 11-21-2024 4:00pm EST
Myomo Inc is a wearable medical robotics company that develops, designs, and produces myoelectric orthotics for people with neuromuscular disorders. The MyoPro myoelectric upper limb orthosis product is registered with the Food and Drug Administration as a Class II medical device. The Company provides the devices to patients and bills their insurance companies directly, sometimes utilizing the clinical services of orthotics and prosthetics providers for which a fee is paid. The Company sells the product to orthotics and prosthetics providers around the world and the Veterans Health Administration (VA).
| Founded: | 2004 | Country: | United States |
| Employees: | N/A | City: | BOSTON |
| Market Cap: | 113.3M | IPO Year: | 2017 |
| Target Price: | $7.75 | AVG Volume (30 days): | 199.1K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 4 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.28 | EPS Growth: | N/A |
| 52 Week Low/High: | $2.51 - $5.64 | Next Earning Date: | 11-06-2024 |
| Revenue: | $25,239,125 | Revenue Growth: | 36.23% |
| Revenue Growth (this year): | 53.19% | Revenue Growth (next year): | 39.01% |
Stock Insider Trading Activity of Myomo Inc. (MYO)
| Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Kovelman Harry | MYO | Chief Medical Officer | Sep 5 '24 | Sell | $3.76 | 6,700 | $25,182.62 | 123,556 | |
| Kovelman Harry | MYO | Chief Medical Officer | Sep 3 '24 | Sell | $4.01 | 2,029 | $8,140.35 | 123,556 |
Latest Myomo Inc. News
MYO Breaking Stock News: Dive into MYO Ticker-Specific Updates for Smart Investing
GuruFocus.com
15 days ago
Myomo Inc (MYO) Q3 2024 Earnings Call Highlights: Record Revenue and Strategic Growth Initiatives
Zacks
15 days ago
Myomo, Inc. (MYO) Reports Q3 Loss, Tops Revenue Estimates
Business Wire
15 days ago
Myomo Reports Record Third Quarter Financial and Operating Results
GuruFocus.com
16 days ago
Myomo Inc (MYO) Q3 2024: Everything You Need To Know Ahead Of Earnings
Business Wire
21 days ago
Myomo Announces First Private Payer Contracts for MyoPro In-network Coverage
Business Wire
22 days ago
Myomo to Report Third Quarter Financial Results on November 6, 2024
GuruFocus.com
a month ago
Rosalind Advisors, Inc. Expands Stake in Myomo Inc
GuruFocus.com
a month ago
Myomo Inc (MYO) Q2 2024 Earnings Call Highlights: Record Revenue Growth and Strategic Expansion ...
Compare MYO vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "MYO Myomo Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.